Carin Stutz bought $79k of KRUS
director at KURA SUSHI USA, INC.. 1,500 shares at an average of $52.37, traded Nov 13, 2023, filed Nov 15, 2023.
Score components
- +15RoleDirector
- +9Trade size$79k at market
- +10Relative to holdingsHoldings up 130%
- +8Price context52% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +17.3%, 3m +69.1%, 6m +81.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-23-064158, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 13, 2023 | POpen-market purchase Class A Common Stock | +1,500 | $52.37 | $79k | 2,654 | Nov 15, 2023 |
Related signals
Other insiders at KURA SUSHI USA, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | KURA SUSHI USA, INC. | Hajime Uba SEE REMARKS (a) | $720k 9,874 shares | -62% | |
| 39Weak | KRUSsell KURA SUSHI USA, INC. | Seitaro Ishii director | $574k 6,918 shares | -84% | |
| 45Moderate | KRUSsell KURA SUSHI USA, INC. | Brent Takao See Remarks (a) | $1.3M 14,422 shares | -216% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.